--- title: "Guangzheng Eye Hospital Group Co.Ltd (002524.SZ)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/002524.SZ.md" symbol: "002524.SZ" name: "Guangzheng Eye Hospital Group Co.Ltd" industry: "Health Care Facilities" --- # Guangzheng Eye Hospital Group Co.Ltd (002524.SZ) | Item | Detail | |------|--------| | Industry | Health Care Facilities | | Location | CN Market | | Website | [www.gzjt.cc](https://www.gzjt.cc) | ## Company Profile Guangzheng Eye Hospital Group Co., Ltd. provides various ophthalmic medical services in China. It operates through Steel Structure Segment; Energy Segment; and Medical and Health segment. The steel structure segment engaged in steel structure processing and sales and installation business. ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-20T04:30:09.000Z **Overall: D (0.74)** **Industry**: Health Care Facilities | Metric | Value | |--------|-------| | Industry Ranking | 9 / 9 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -9.43% | | | Net Profit YoY | -598.84% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 21.74 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 2.44B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 857.57M | | **Multi Score**: D #### Profit Score: E | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -77.83% | E | | Profit Margin | -17.92% | D | | Gross Margin | 34.49% | C | #### Growth Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -9.43% | D | | Net Profit YoY | -598.84% | E | | Total Assets YoY | -15.15% | E | | Net Assets YoY | -54.16% | E | #### Cash Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -558.04% | E | | OCF YoY | -9.43% | D | #### Operating Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.65 | B | #### Debt Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 89.56% | E | ```chart-data:radar { "title": "Longbridge Financial Score - Guangzheng Eye Hospital Group Co.Ltd", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "E", "indicators": [ { "name": "ROE", "value": "-77.83%", "rating": "E" }, { "name": "Profit Margin", "value": "-17.92%", "rating": "D" }, { "name": "Gross Margin", "value": "34.49%", "rating": "C" } ] }, { "name": "Growth", "grade": "E", "indicators": [ { "name": "Revenue YoY", "value": "-9.43%", "rating": "D" }, { "name": "Net Profit YoY", "value": "-598.84%", "rating": "E" }, { "name": "Total Assets YoY", "value": "-15.15%", "rating": "E" }, { "name": "Net Assets YoY", "value": "-54.16%", "rating": "E" } ] }, { "name": "Cash", "grade": "E", "indicators": [ { "name": "Cash Flow Margin", "value": "-558.04%", "rating": "E" }, { "name": "OCF YoY", "value": "-9.43%", "rating": "D" } ] }, { "name": "Operating", "grade": "B", "indicators": [ { "name": "Turnover", "value": "0.65", "rating": "B" } ] }, { "name": "Security", "grade": "E", "indicators": [ { "name": "Gearing Ratio", "value": "89.56%", "rating": "E" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Aier (SZ.300015) | B | C | B | B | C | B | | 02 | Sanbo (SZ.301293) | C | B | C | B | B | B | | 03 | INKON Life (SZ.300143) | C | B | C | B | B | B | | 04 | Huaxia Eye (SZ.301267) | B | C | C | B | C | C | | 05 | Innovative Medical (SZ.002173) | D | D | C | A | D | C | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -15.86 | 6/9 | - | - | - | | PB | 21.74 | 9/9 | 20.96 | 19.43 | 18.06 | | PS (TTM) | 2.84 | 4/9 | 2.75 | 2.61 | 2.38 | | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/002524.SZ/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/002524.SZ/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/002524.SZ/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.